Skip to content
DataLookout
Menu

NCT07266389

Clinical Efficacy Evaluation of Supraglottic Airway Device SafeLM™ in Paediatric Population

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 6 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 30, 2026 to Nov 30, 2026 Show 5 more changesShow less
    • Recruitment opened
    • Eligibility criteria expanded, about 9 words
    • Study completion pushed from May 30, 2026 to Dec 30, 2026
    • Secondary endpoints: details revised at 3 of 12 entries
    • Site details revised at 2 of 2 sites
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Success rate of device placement in percentage
Timeframe: Perioperative
Oropharyngeal leak pressure (OPLP) in cmH2O
Timeframe: From the time of successful device placement confirmation to the time of determination of OPLP before commencement of surgery
Glottic exposure grades
Timeframe: At the time of completion of device placement procedure, when the distal end of the cuff reaches the hypopharyngeal cavity, resistance is met, and the cuff is inflated with appropriate volume of air as per manufacturer recommendation.

Secondary (12)

Insertion time in seconds (s)
The ease of SafeLM™ insertion
Anaesthetists' overall satisfactory score
Rate of intraoperative laryngospasm
Rate of intraoperative bronchospasm
Show 7 moreShow less
Rate of intraoperative desaturation event
Rate of intraoperative gastric aspiration event
Rate of post-extubation gastric aspiration event
Rate of post-extubation sore throat event
Rate of post-extubation finding of blood stain
Rate of post-extubation laryngospasm
Rate of post-extubation bronchospasm

Arms and interventions

Usage of SafeLM™ as the airway deviceExperimental

SafeLM™ will be the airway device used for ventilation throughout the general anaesthesia period

Devices: SafeLM™ as the airway management device during general anaesthesia

Sites

2 sites in 1 country